Hypofractionated Radiation Therapy (HFRT) of Breast/Chest …
2022年4月1日 · Hypofractionated radiotherapy (HFRT) is currently recommended by several international guidelines for early breast cancer without nodal involvement and after breast …
HFRT和CFRT模式对乳腺癌患者外周血淋巴细胞的影响
摘要： 目的 探讨不同放疗分割模式即大分割放疗（hypofractionated radiotherapy, HFRT)和常规分割放疗（conventional fractionation radiotherapy, CFRT)对乳腺癌患者外周血淋巴细胞的影响 …
Hypofractionated vs. Conventional Radiation Therapy for Stage III …
Hypofractionated RT (HFRT) regimens, in which radiation is administered using larger doses per fraction over a shorter period of time, are becoming increasingly common.
Real-World Practice of Hypofractionated Radiotherapy in Patients …
Application of hypofractionated radiotherapy (HFRT) is growing in patients with breast cancer (BC). This study aimed to explore a real-world practice of HFRT in early and locally advanced …
The efficacy of hypofractionated radiotherapy (HFRT) with ... - PubMed
Compared with survival data for standard treatment, HFRT seemed to improve overall survival and progression-free survival, while high BED schedules may future increase benefit on PFS. …
Hypofractionated Radiotherapy in Treatment of Cervical Cancer: A ...
2024年10月1日 · Hypofractionated RT (HFRT) is the delivery of larger radiation doses (> 2.2Gy) per fraction over a shorter treatment duration. While HFRT improves patient compliance, data …
Evidence-based clinical recommendations for hypofractionated ...
Moderately hypofractionated RT (HFRT) regimens for prostate cancer with a fraction size of 2.4–4 Gy over 4–6 weeks have shown non-inferior efficacy and similar toxicities in clinical trials [8 - …
【综述】基于证据的大分割放疗的临床推荐:疗效和安全性的探索
sbrt或hfrt具有治疗时间短、急性毒性小、顺应性好等优点，但也有可能对器官造成永久性损伤。一些研究报道了sbrt和hfrt对老年头颈癌患者的疗效和毒性(表4)。 表4。报告老年患者hfrt结果的 …
Hypofractionated radiotherapy with simultaneous tumor bed …
2024年5月27日 · The effectiveness and safety of moderately hypofractionated radiotherapy (HFRT) in patients undergoing breast-conserving surgery (BCS) has been demonstrated in …
靶向肿瘤免疫微环境：卢铀教授团队首次揭示低剂量放射治疗及大 …
为进一步评估三联治疗方案的临床疗效，卢铀教授团队还回顾性分析了9例接受 LDRT+HFRT+免疫治疗的晚期非小细胞肺癌患者（多为2线或以上治疗失败的患者）。 结果显示 3例患者最佳疗 …